Euclidean Capital as of June 30, 2024
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 78.4 | $624M | 1.1M | 544.22 | |
| Ishares Tr Msci India Etf (INDA) | 17.0 | $135M | 2.4M | 55.78 | |
| Foghorn Therapeutics (FHTX) | 1.1 | $9.0M | 1.6M | 5.75 | |
| Oric Pharmaceuticals (ORIC) | 0.9 | $7.0M | 989k | 7.07 | |
| Alector (ALEC) | 0.7 | $5.9M | 1.3M | 4.54 | |
| Pmv Pharmaceuticals (PMVP) | 0.5 | $4.3M | 2.6M | 1.62 | |
| 23andme Holding Class A Com | 0.5 | $4.0M | 10M | 0.39 | |
| Tenaya Therapeutics (TNYA) | 0.4 | $3.1M | 1.0M | 3.10 | |
| Rapt Therapeutics | 0.3 | $2.0M | 658k | 3.05 | |
| Surrozen Com New (SRZN) | 0.1 | $960k | 88k | 10.95 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.8k | 171k | 0.02 |
